Catherine Schulte
Stock Analyst at Baird
(4.07)
# 501
Out of 4,896 analysts
130
Total ratings
56.36%
Success rate
10.39%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $159 → $140 | $120.67 | +16.02% | 16 | May 22, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $2.70 | -25.79% | 6 | May 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $69 → $72 | $54.31 | +32.57% | 14 | May 2, 2025 | |
| AVTR Avantor | Maintains: Outperform | $21 → $17 | $13.31 | +27.72% | 11 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $603 → $573 | $427.10 | +34.16% | 26 | Apr 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $231 → $225 | $198.67 | +13.25% | 9 | Apr 23, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,369 → $1,034 | $1,203.21 | -14.06% | 8 | Apr 22, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $48.32 | -11.00% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $53.18 | +27.87% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $19.43 | +95.57% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $37.79 | -12.68% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $98.75 | +184.56% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $310.22 | -30.05% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $158.74 | -87.40% | 1 | Jun 28, 2018 |
Agilent Technologies
May 22, 2025
Maintains: Outperform
Price Target: $159 → $140
Current: $120.67
Upside: +16.02%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $2.70
Upside: -25.79%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $69 → $72
Current: $54.31
Upside: +32.57%
Avantor
Apr 28, 2025
Maintains: Outperform
Price Target: $21 → $17
Current: $13.31
Upside: +27.72%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $603 → $573
Current: $427.10
Upside: +34.16%
Danaher
Apr 23, 2025
Maintains: Outperform
Price Target: $231 → $225
Current: $198.67
Upside: +13.25%
Mettler-Toledo International
Apr 22, 2025
Maintains: Neutral
Price Target: $1,369 → $1,034
Current: $1,203.21
Upside: -14.06%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $48.32
Upside: -11.00%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $53.18
Upside: +27.87%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $19.43
Upside: +95.57%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $37.79
Upside: -12.68%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $98.75
Upside: +184.56%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $310.22
Upside: -30.05%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $158.74
Upside: -87.40%